<SEC-DOCUMENT>0001213900-17-004429-index.html : 20170501
<SEC-HEADER>0001213900-17-004429.hdr.sgml : 20170501
<ACCEPTANCE-DATETIME>20170501122050
ACCESSION NUMBER:		0001213900-17-004429
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170501
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170501
DATE AS OF CHANGE:		20170501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DanDrit Biotech USA, Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54478
		FILM NUMBER:		17799443

	BUSINESS ADDRESS:	
		STREET 1:		DANDRIT BIOTECH A/S
		STREET 2:		FRUEBJERGVEJ 3 BOX 62
		CITY:			2100 COPENHAGEN
		STATE:			G7
		ZIP:			0
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		DANDRIT BIOTECH A/S
		STREET 2:		FRUEBJERGVEJ 3 BOX 62
		CITY:			2100 COPENHAGEN
		STATE:			G7
		ZIP:			0

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Putnam Hills Corp.
		DATE OF NAME CHANGE:	20110810
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k050117_dandritbiotech.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k050117_dandritbiotech.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>f8k050117ex10i_dandritbio.htm
<DESCRIPTION>FORM OF SUBSCRIPTION AGREEMENT
<TEXT>
Document 2 - file: f8k050117ex10i_dandritbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>f8k050117ex10ii_dandritbio.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
Document 3 - file: f8k050117ex10ii_dandritbio.htm

</DOCUMENT>
</SEC-DOCUMENT>